Literature DB >> 21473259

High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women.

E Oda1, R Kawai.   

Abstract

Among five components of metabolic syndrome, high-density lipoprotein (HDL) cholesterol is unique because it is not significantly associated with blood pressure. This study looks at cross-sectional relationships between HDL cholesterol and hypertension using medical check-up data from 1803 apparently healthy Japanese men aged 49.9 +/- 9.0 years, and 1150 Japanese women aged 49.5 +/- 9.0 years. Pearson's correlation coefficients between systolic blood pressure (SBP)/diastolic blood pressure (DBP) and HDL cholesterol were -0.01 (ns)/-0.01 (ns) in men and -0.04 (ns)/-0.01 (ns) in women. The standardised partial regression coefficient of HDL cholesterol for SBP/DBP (mmHg) controlling for age, body mass index (BMI), fasting plasma glucose (FPG), triglycerides, high-sensitivity C-reactive protein (hs-CRP) and low-density lipoprotein (LDL) cholesterol were 0.15 (P < 0.0001)/0.15 (P < 0.0001) in men and 0.10 (P < 0.0001)/0.12 (P < 0.0001) in women. The odds ratio (OR; 95% confidence interval [CI]) of a 1 mg/dL increment of HDL cholesterol for hypertension controlling for age, BMI, FPG, triglycerides, hs-CRP, LDL cholesterol, metabolic syndrome, diabetes, exercise status, drinking status, and smoking status was 1.03 (1.02-1.04; P < 0.001) in men and 1.03 (1.01-1.05; P = 0.002) in women. Thus, HDL cholesterol was independently positively associated with hypertension in apparently healthy Japanese men and women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473259     DOI: 10.1080/09674845.2011.11732838

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  7 in total

1.  Increased high-density lipoprotein cholesterol is associated with a high prevalence of pre-hypertension and hypertension in community-dwelling persons.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Masanori Abe; Tomo Kusunoki
Journal:  Endocrine       Date:  2012-03-14       Impact factor: 3.633

2.  Case-control study on peroxisome proliferator-activated receptor gamma polymorphism and interaction with HDL on essential hypertension in Chinese Han.

Authors:  Gang Wang; Ping Xu; Wei Feng; Xianyan Jiang; Tao Zhang; Jian Li
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

3.  High normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study.

Authors:  Yen-Lin Chen; Chun-Hsien Hsu; Chang-Hsun Hsieh; Chung-Ze Wu; Jiunn-Diann Lin; Jin-Biou Chang; Yao-Jen Liang; Yi-Ting Tsai; Te-Lin Hsia; Dee Pei
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

4.  Association between high-density lipoprotein-cholesterol and hypertension in relation to circulating CD34-positive cell levels.

Authors:  Yuji Shimizu; Shimpei Sato; Jun Koyamatsu; Hirotomo Yamanashi; Mako Nagayoshi; Koichiro Kadota; Shin-Ya Kawashiri; Takahiro Maeda
Journal:  J Physiol Anthropol       Date:  2017-06-15       Impact factor: 2.867

5.  Smoking was a Possible Negative Predictor of Incident Hypertension After a Five-Year Follow-up Among a General Japanese Population.

Authors:  Masanori Kaneko; Eiji Oda; Hiromi Kayamori; Satomi Nagao; Hiroshi Watanabe; Takahiro Abe; Masahiro Ishizawa; Yasuyuki Uemura; Yoshifusa Aizawa
Journal:  Cardiol Res       Date:  2012-03-20

6.  Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study.

Authors:  Wen-Rui Shi; Hao-Yu Wang; Shuang Chen; Xiao-Fan Guo; Zhao Li; Ying-Xian Sun
Journal:  Lipids Health Dis       Date:  2018-10-12       Impact factor: 3.876

7.  Associations between the lipid profile and the development of hypertension in young individuals - the preliminary study.

Authors:  Piotr Chruściel; Paulina Stemplewska; Adam Stemplewski; Mohamad Wattad; Agata Bielecka-Dąbrowa; Marek Maciejewski; Peter Penson; Marcin A Bartlomiejczyk; Maciej Banach
Journal:  Arch Med Sci       Date:  2019-06-27       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.